Finance Home - My Yahoo - Yahoo! - Help

Saturday, November 28, 2009, 9:43AM ET - U.S. Markets Closed. Dow  1.48% Nasdaq  1.73%

Albany Molecular Research Inc. (AMRI)

On Nov 27: 8.43   0.15 (1.75%)

MORE ON AMRI

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Income Statement Get Income Statement for:

View: Annual Data | Quarterly Data All numbers in thousands PERIOD ENDING 31-Dec-08 31-Dec-07 31-Dec-06 Total Revenue 229,260   192,511   179,807   Cost of Revenue 148,976   132,032   128,610   Gross Profit 80,284   60,479   51,197   Operating Expenses Research Development 13,129   12,821   11,428   Selling General and Administrative 39,361   36,034   34,682   Non Recurring 1,833   273   5,985   Others -   -   -   Total Operating Expenses -   -   -   Operating Income or Loss 25,961   11,351   (898) Income from Continuing Operations Total Other Income/Expenses Net 2,422   3,887   4,212   Earnings Before Interest And Taxes 28,383   15,238   3,314   Interest Expense 493   853   1,072   Income Before Tax 27,890   14,385   2,242   Income Tax Expense 7,330   5,449   59   Minority Interest -   -   -   Net Income From Continuing Ops 20,560   8,936   2,183   Non-recurring Events Discontinued Operations -   -   -   Extraordinary Items -   -   -   Effect Of Accounting Changes -   -   -   Other Items -   -   -   Net Income 20,560   8,936   2,183   Preferred Stock And Other Adjustments -   -   -   Net Income Applicable To Common Shares $20,560   $8,936   $2,183

Add to Portfolio     Set Alert     Email to a Friend Get Income Statement for Another Symbol: Symbol Lookup • Sector Analysis Sign Up for a Free Trial to EDGAR Online Premium! Get the critical business and financial information you need for more than 15,000 U.S. public companies. Sign Up Now - Learn More